Antibodies from llamas can neutralise the coronavirus

London: Scientists have demonstrated that two small, stable antibody variants derived from the South American mammals llamas can neutralise the novel coronavirus in lab-cultured cells, an advance which may lead to the development of new therapeutics against COVID-19. The study, published in the journal Nature Structural & Molecular Biology, noted that the 'nanobodies' extracted from the llamas can prevent infection by blocking the interaction between the novel coronavirus and the protein ACE2, which it uses as a gateway to enter and infect cells.

Thus, the nanobodies, either alone, or in combination with other antibodies, may find application for passive immunisation of patients with severe COVID-19. The researchers explained that human antibodies, like those of most mammals, have two chains -- heavy and light -- but camelids, such as llamas, also possess an additional single heavy chain antibody variant, known as a nanobody. Nanobodies are small, stable and easily produced and thus often serve as alternatives to conventional antibodies for diagnostics and imaging, the scientists said.

(To view our epaper please click here. For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)

Free Press Journal

www.freepressjournal.in